reports
- ING Helpdesk
REVISED VERSION - Benelux Morning Notes - updated to include IBA news
CFE: 1H results a bit light, FY outlook maintained. CMB.TECH: VLCC reasonable, pressure on Dry Bulk rates. dsm-firmenich: Givaudan CMD; Strategy 2030. Gimv: Investing in specialised healthcare services in the Netherlands. IBA: More sales but at lower margin
- Hilde Van Boxstael
- Kristof Samoy
- Livio Luyten
- Lynn Hautekeete
- Michiel Declercq
- Wim Lewi
IBA reports strong Half Year 2025 results, transforming towards a more...
IBA reports strong Half Year 2025 results, transforming towards a more profitable business Read the entire half year 2025 results press release Louvain-la-Neuve, Belgium, 28 August 2025 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its consolidated results for the first half of 2025. High revenue growth and improved profitability in H1 driven by accelerated backlog conversion Net sales rose 40% vs. H1 2024, to EUR 304.9 million, with IBA Clinical and IBA Technologies increasing by 47% and 30% respectively thanks to well-exec...
IBA réalise des résultats solides au premier semestre 2025, évoluant v...
IBA réalise des résultats solides au premier semestre 2025, évoluant vers une plus haute profitabilité pour lire l'intégralité du communiqué de presse des résultats du premier semestre 2025 Louvain-La-Neuve, Belgique, 28 août 2025 - IBA (Ion Beam Applications S.A.), le leader mondial de la technologie d’accélération de particules, annonce ce jour ses résultats consolidés du premier semestre (S1) 2025. Forte croissance du chiffre d'affaires et amélioration de la rentabilité au S1, grâce à l'accélération de la conversion du carnet de commandes Chiffre d'affaires net en augmentation de ...
- Dirk Verbiesen
- Quirijn Mulder
Fugro/Trough passed/BUY
We expected a halving of EBIT YoY, but it was more as 2Q25 ended at -80% largely due to US offshore wind, lower vessel availability and postponements of large contracts. Fugro expects 2H revenues to increase by 20% HoH as elements of the downturn should not return in 3Q/4Q such as vessels and project postponements. Consequently, with delayed contracts now being executed, we feel comfortable with the company's view on 2H25. Including 2Q25, we have lowered our FY25-27F estimates, for the third tim...
Progress on share buyback programme
Progress on share buyback programme Progress on share buyback programme ING announced today that, as part of our €2.0 billion share buyback programme announced on 2 May 2025, in total 2,361,034 shares were repurchased during the week of 18 August 2025 up to and including 22 August 2025. The shares were repurchased at an average price of €21.31 for a total amount of €50,309,433.36. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the ING website at . In line with the purpose of the programme to reduce the share capita...
- David Vagman
- CFA
- Maxime Stranart
Lotus Bakeries/1H25 results: factory to open ahead of schedule/BUY
We reiterate our BUY on Lotus Bakeries but lower our target price from €12,000 to €10,300 on the back of lower short-term estimates, due to the deconsolidation of ice cream and chocolate sales, as well as a higher WACC. We believe that Lotus Bakeries has underperformed key peers Mondelez and Lindt & Sprüngli this year due to investor concerns on constrained volume growth for Lotus Biscoff and to a potential slowdown in Natural Foods growth. We note that both those concerns have been put to rest ...
- Maxime Stranart
- Reg Watson
- CFA
Ontex/1H25 postview: weak 1H25 and profit warning/HOLD
We reiterate our HOLD rating on Ontex but lower our target price from €8.2 to €7.4 following the group's profit warning in 1H25, leading to our Adj. EBITDA forecast to drop by 12% in 2025F. We continue to expect Ontex's heavy restructuring plan to remain a drag on short-term operational performance, despite an elevated capex spend over the year. At €7.4, Ontex would trade at 6.2/5.2x EV/Adj. EBITDA 2025/26F (incl. Factoring), a discount of 45-50% to branded Hygiene Products peers we deem warrant...
Transparency Declaration Notification
Transparency Declaration Notification Regulatory information In accordance with the requirements of Article 14 of the Belgian Law of May 2, 2007 on the disclosure of significant shareholdings in listed companies, Ontex Group NV (“Ontex”) discloses the notifications of significant shareholding by the Goldman Sachs Group, Inc., that it has received on August 19, 20, 21 and 22, 2025. On August 13, 2025, the Goldman Sachs Group, Inc., detained 94,311 Ontex voting rights and 2,425,641 equivalent financial instruments, representing 3.06% of voting rights combined. The combined holding thereb...
Kennisgeving transparantieverklaring
Kennisgeving transparantieverklaring Gereglementeerde informatie In overeenstemming met de vereisten van artikel 14 van de Belgische wet van 2 mei 2007 over de openbaarmaking van belangrijke deelnemingen in emittenten, maakt Ontex Group NV (“Ontex”) de verklaringen van belangrijke deelnemingen door Goldman Sachs Group, Inc., bekend die op 19, 20, 21 en 22 augustus 2025 werden ontvangen. Op 13 augustus 2025 bezat de Goldman Sachs Group, Inc., 94.311 stemrechten en 2.425.641 equivalente financiële instrumenten van Ontex, wat gecombineerd 3,06% van de stemrechten uitmaakt. De gecombineerd...
- Wim Lewi
EnergyVision It's a beautiful day, don't let it slip away
We initiate on EnergyVision 40 days after its successful IPO. We believe that the positive vibe from the stock market entry will reflect in its future business development. Credibility and brand recognition are key for an energy supplier. We also like its focus on the energy transition. This segment recovers from an over-excitement period (2021-22). Today's market is all about AI and Defence, while climate change is becoming more apparent with every wild fire or glacier collapse. Their customer...
- ING Helpdesk
Benelux Morning Notes
Ackermans & van Haaren: Expect buoyed contribution from Private Banking. ASR: 1H: strong solvency, buyouts at 12% IRR. Deceuninck: Weak set of results, as expected following the change in CEO. EVS: Very weak 1H25, but guidance unchanged; convincing bolt-on deal in the US. IBA: IBA to install one P1 system at university campus in Heidelberg, Germany. NEPI Rockcastle: Robust performance, small upward revision to guidance
- Guy Sips
- Kristof Samoy
- Livio Luyten
- Michiel Declercq
- Thomas Couvreur
- Wim Hoste
- Wim Lewi
Heidelberg University Hospital expands its particle therapy program wi...
Heidelberg University Hospital expands its particle therapy program with IBA’s Proteus®ONE solution Louvain-La-Neuve, Belgium, August 20, 2025 – (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer and Heidelberg University Hospital (Universitätsklinikum Heidelberg AöR, UKHD) announce today that they have signed a contract to install a Proteus®ONE1 compact proton therapy solution to be located on the University campus in Heidelberg, Germany. The first payment ...
L'hôpital universitaire de Heidelberg élargit son programme de thérapi...
L'hôpital universitaire de Heidelberg élargit son programme de thérapie par particules avec une solution Proteus®ONE Louvain-la-Neuve, Belgique, le 20 août 2025 - IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules et principal fournisseur de solutions de protonthérapie pour le traitement du cancer, et l'hôpital universitaire de Heidelberg (Universitätsklinikum Heidelberg AöR, UKHD) annoncent aujourd'hui la signature d'un contrat pour l'installation d'une solution compacte de protonthérapie Proteus®ONE1 sur le campus universitaire...
Progress on share buyback programme
Progress on share buyback programme Progress on share buyback programme ING announced today that, as part of our €2.0 billion share buyback programme announced on 2 May 2025, in total 2,493,940 shares were repurchased during the week of 11 August 2025 up to and including 15 August 2025. The shares were repurchased at an average price of €21.04 for a total amount of €52,480,262.49. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the ING website at . In line with the purpose of the programme to reduce the share capit...
Transparency Declaration Notification
Transparency Declaration Notification Regulated information In accordance with the requirements of Article 14 of the Belgian Law of May 2, 2007 on the disclosure of significant shareholdings in listed companies, Ontex Group NV (“Ontex”) discloses the notifications of significant shareholdings by the Goldman Sachs Group, Inc., that it has received on August 13 and 14, 2025. On August 7, 2025, the Goldman Sachs Group, Inc., detained 2,559,642 Ontex voting rights or equivalent financial instruments, representing 3.11% of voting rights, and thereby crossed upward the threshold of 3.0%. On Au...
Kennisgeving transparantieverklaring
Kennisgeving transparantieverklaring Geregelementeerde informatie In overeenstemming met de vereisten van artikel 14 van de Belgische wet van 2 mei 2007 over de openbaarmaking van belangrijke deelnemingen in emittenten, maakt Ontex Group NV (“Ontex”) de verklaringen van belangrijke deelnemingen door Goldman Sachs Group, Inc., bekend die op 13 en 14 augustus 2025 werden ontvangen. Op 7 augustus 2025 bezat Goldman Sachs Group, Inc., 2.559.642 stemrechten of equivalente financiële instrumenten van Ontex, wat 3,11% van de stemrechten voorstelt. Zij hebben daarmee de drempel van 3,0% opwaarts ...
- Hilde Van Boxstael
- Jacob Mekhael
- Kristof Samoy
- Livio Luyten
- Lynn Hautekeete
- Michiel Declercq
- Thomas Couvreur
- Wim Lewi
- Kristof Samoy
Fugro A Convincing Path to 2H Recovery & Deep Discount Opportunity
We revisited our case following the recent profit warning but recognise 2Q25 already showed a remarkable q/q improvement in profitability to be continued in 2H25. The cheap valuation, strong balance sheet (1.2x EBITDA leverage and no debt maturities prior to 2029) next to the optionality in the future capex spend make that Fugro can weather further storms should they occur. At the speculative front with the mid and long term fundamentals intact potential renewed ownership interest by cash rich d...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.